Name: Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD by Oncology Data Advisor® in ASH Annual Meeting 2022: Leukemias and Myeloproliferative Neoplasms
Duration: 13 min 3 s
Description: This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!

This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!

ASH Annual Meeting 2022: Leukemias and Myeloproliferative Neoplasms

Investigating Momelotinib for Treatment of Myelofibrosis With Srdan Verstovsek, MD, PhD

Studying Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia With Jorge Cortes, MD

Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD

LAST CHANCE – Expires November 21!

Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.

Listen now and earn 0.5 CME credit: bit.ly/49GyP5T

EXPIRING SOON! Diagnosis and Management of Dedifferentiated Liposarcoma

Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions.

In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, provides essential insights and testing recommendations to optimize patient care. Listen now!

Click here to claim CME/NCPD credit: bit.ly/49NCaQu

EXPIRING SOON! What’s New With HER2: Charting New Paths in NSCLC Care - Module 1: Actionable Insights and Testing Recommendations

Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies.

In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, explores advanced testing methodologies and strategies to navigate HER2 complexities and optimize patient outcomes. Listen now!

Click here to claim CME/NCPD credit: bit.ly/405xEJO

EXPIRING SOON! What’s New With HER2: Charting New Paths in NSCLC Care - Module 2: Current and Emerging Treatments for HER2-Mutated NSCLC

Join Lauren M. Madigan, MD, Associate Professor of Dermatology at the University of Utah, for a sneak peek at our upcoming live webinar, Beyond the Skin: Uncovering Systemic Mastocytosis (SM) in Dermatology Practice. In this short interview, Dr. Madigan shares practical insights on why SM is so often diagnosed late, how skin findings can be a key clue to recognition, and what’s new in the rapidly evolving world of targeted therapies.

The webinar will be offered on two dates. Click the links to register for the date that fits your schedule best!

Tuesday, January 13 at 5:00 pm ET - https://bit.ly/4p7HRil
Monday, February 2 at 7:00 pm ET - https://bit.ly/495gnEd


Discovering Systemic Mastocytosis in Practice: A Webinar Preview With Lauren M. Madigan, MD

Join Lauren M. Madigan, MD, Associate Professor of Dermatology at the University of Utah, for a sneak peek at our upcoming live webinar, Beyond the Skin: Uncovering Systemic Mastocytosis (SM) in Dermatology Practice. In this short interview, Dr. Madigan shares practical insights on why SM is so often diagnosed late, how skin findings can be a key clue to recognition, and what’s new in the rapidly evolving world of targeted therapies.

The webinar will be offered on two dates. Click the links to register for the date that fits your schedule best!

Tuesday, January 13 at 5:00 pm ET - bit.ly/4p7HRil
Monday, February 2 at 7:00 pm ET - bit.ly/495gnEd

Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on optimizing HER2 testing and integrating the latest targeted therapies into your practice. They’ll walk through how to improve detection and ensure your patients are getting the most effective, up-to-date treatments available.

You can catch the live session on either of these dates:

Wednesday, January 8 at 5:00 pm ET: https://bit.ly/4iZxnA0
Monday, January 26 at 5:00 pm ET: https://bit.ly/4qALw9J

Navigating HER2-Mutant NSCLC Pathology and Management: A Webinar Preview With Helena A. Yu, MD, and Maria Arcila, MD

Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on optimizing HER2 testing and integrating the latest targeted therapies into your practice. They’ll walk through how to improve detection and ensure your patients are getting the most effective, up-to-date treatments available.

You can catch the live session on either of these dates:

Wednesday, January 8 at 5:00 pm ET: bit.ly/4iZxnA0
Monday, January 26 at 5:00 pm ET: bit.ly/4qALw9J

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD

Oncology Data Advisor®

Related tracks